Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening data.
Chemogenomic approaches involving highly annotated compound sets and cell based high throughput screening are emerging as a means to identify novel drug targets. We have previously screened a collection of highly characterized kinase inhibitors (Khan et al., Journal of General Virology, 2016) to ide...
Main Authors: | Blair L Strang, Christopher R M Asquith, Hanan F Moshrif, Catherine M-K Ho, William J Zuercher, Hassan Al-Ali |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6062112?pdf=render |
Similar Items
-
New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K)
by: Christopher R. M. Asquith, et al.
Published: (2020-04-01) -
Synergistic HIV latency reversal from an in vitro screen of epigenetic and kinase inhibitors
by: D. Irlbeck, et al.
Published: (2017-12-01) -
Differential Effects of Phosphatidylinositol 4-Kinase (PI4K) and 3-Kinase (PI3K) Inhibitors on Stomatal Responses to Environmental Signals
by: Koh Iba, et al.
Published: (2017-05-01) -
Design and Synthesis of Oxazolo[4,5- d]pyrimidine Compounds as Aurora Kinase Inhibitors
by: Chen, Li-Chun, et al.
Published: (2010) -
Controlling Cytomegalovirus: Helping the Immune System Take the Lead
by: Patrick J. Hanley, et al.
Published: (2014-05-01)